Avalo Therapeutics, Inc. SEC filings AVTX

Avalo Therapeutics, Inc. has 1,002 filings in SEC EDGAR's recent list, going back to May 9, 2017. Its latest annual report, Form ARS, was filed on Apr 10, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (material agreement, agreement ended). The company's fiscal year ends on December 31.

Avalo Therapeutics, Inc. SEC filings
Form Description Filed Period
8-K Current report
Material agreement, Agreement ended
Nov 5, 2026 Nov 5, 2026
S-3ASR Automatic shelf registration Nov 5, 2026 —
424B5 Prospectus supplement Nov 5, 2026 —
10-Q Quarterly report Nov 5, 2026 Sep 30, 2026
8-K Current report
Results of operations
Nov 5, 2026 Nov 5, 2026
10-Q Quarterly report Aug 6, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 6, 2026 Aug 6, 2026
EFFECT Filing Jul 28, 2026 —
424B3 Prospectus Jul 28, 2026 —
S-3 Shelf registration Jul 17, 2026 —
8-K Current report
Officer or director change
Jun 23, 2026 Jun 23, 2026
8-K Current report
Other events
Jun 16, 2026 Jun 16, 2026
8-K Current report
Unregistered share sale, Change to shareholder rights, Officer or director change, Bylaw or fiscal year change
Jun 12, 2026 Jun 11, 2026
8-K Current report
Officer or director change, Shareholder vote results
Jun 8, 2026 Jun 2, 2026
10-Q Quarterly report May 13, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 13, 2026 May 13, 2026
8-K Current report
Material agreement, Results of operations, Regulation FD disclosure
May 7, 2026 May 5, 2026
424B5 Prospectus supplement May 7, 2026 —
424B5 Prospectus supplement May 5, 2026 —
8-K Current report
Other events
May 5, 2026 May 5, 2026
8-K Current report
Material agreement, Regulation FD disclosure
Apr 28, 2026 Apr 26, 2026
ARS Annual report to shareholders Apr 10, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 10, 2026 —
DEF 14A Proxy statement Apr 10, 2026 Apr 10, 2026
8-K Current report
Officer or director change
Mar 27, 2026 Mar 23, 2026
S-8 Employee stock plan registration Mar 23, 2026 —
10-K Annual report Mar 23, 2026 Dec 31, 2025
8-K Current report
Results of operations
Mar 23, 2026 Mar 23, 2026
EFFECT Filing Jan 20, 2026 —
CORRESP Letter to the SEC Jan 15, 2026 —
UPLOAD Letter from the SEC Jan 14, 2026 —
8-K Current report
Results of operations, Other events
Jan 12, 2026 Jan 12, 2026
S-3 Shelf registration Jan 8, 2026 —
8-K Current report
Other events
Dec 2, 2025 Dec 2, 2025
S-8 Employee stock plan registration Nov 6, 2025 —
10-Q Quarterly report Nov 6, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 6, 2025 Nov 6, 2025
8-K Current report
Other events
Oct 29, 2025 Oct 29, 2025
8-K Current report
Other events
Oct 10, 2025 Oct 10, 2025
8-K Current report
Officer or director change, Other events
Oct 1, 2025 Sep 29, 2025
8-K Current report
Officer or director change
Sep 22, 2025 Sep 16, 2025
10-Q Quarterly report Aug 7, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 7, 2025 Aug 7, 2025
8-K Current report
Other events
Jun 20, 2025 Jun 20, 2025
8-K Current report
Officer or director change, Other events
Jun 18, 2025 Jun 17, 2025
8-K Current report
Shareholder vote results
Jun 17, 2025 Jun 17, 2025
8-K Current report
Material agreement, Agreement ended
Jun 5, 2025 Jun 3, 2025
424B5 Prospectus supplement Jun 5, 2025 —
8-K Current report
Other events
Jun 4, 2025 Jun 4, 2025
S-8 Employee stock plan registration May 12, 2025 —
S-8 Employee stock plan registration May 12, 2025 —
10-Q Quarterly report May 12, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 12, 2025 May 12, 2025
8-K Current report
Other events
May 8, 2025 May 8, 2025
ARS Annual report to shareholders May 1, 2025 Dec 31, 2024
DEFA14A Additional proxy material May 1, 2025 —
DEF 14A Proxy statement May 1, 2025 Jun 17, 2025
8-K Current report
Officer or director change, Other events
Mar 26, 2025 Mar 25, 2025
10-K Annual report Mar 20, 2025 Dec 31, 2024
8-K Current report
Results of operations
Mar 20, 2025 Mar 20, 2025
8-K Current report
Other events
Jan 13, 2025 Jan 13, 2025
8-K Current report
Officer or director change, Other events
Jan 2, 2025 Jan 1, 2025
8-K Current report
Other events
Dec 5, 2024 Dec 5, 2024
8-K Current report
Other events
Nov 12, 2024 Nov 12, 2024
S-8 Employee stock plan registration Nov 7, 2024 —
S-8 Employee stock plan registration Nov 7, 2024 —
10-Q Quarterly report Nov 7, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 7, 2024 Nov 7, 2024
8-K Current report
Other events
Oct 8, 2024 Oct 8, 2024
8-K Current report
Other events
Sep 9, 2024 Sep 9, 2024
8-K Current report
Other events
Sep 4, 2024 Sep 3, 2024
8-K Current report
Officer or director change, Shareholder vote results
Aug 14, 2024 Aug 13, 2024
10-Q Quarterly report Aug 12, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 12, 2024 Aug 12, 2024
UPLOAD Letter from the SEC Aug 6, 2024 —
EFFECT Filing Aug 5, 2024 —
424B3 Prospectus Aug 5, 2024 —
CORRESP Letter to the SEC Aug 1, 2024 —
8-K Current report
Other events
Jul 30, 2024 Jul 29, 2024
CORRESP Letter to the SEC Jul 29, 2024 —
S-3/A Filing Jul 29, 2024 —
UPLOAD Letter from the SEC Jul 24, 2024 —
8-K Current report
Officer or director change, Other events
Jul 16, 2024 Jul 15, 2024
CORRESP Letter to the SEC Jul 11, 2024 —
CORRESP Letter to the SEC Jul 11, 2024 —
S-3/A Filing Jul 11, 2024 —
10-Q/A Amended quarterly report Jul 11, 2024 Mar 31, 2024
8-K Current report
Other events
Jul 9, 2024 Jul 9, 2024
UPLOAD Letter from the SEC Jul 2, 2024 —
UPLOAD Letter from the SEC Jul 2, 2024 —
ARS Annual report to shareholders Jun 27, 2024 Dec 31, 2023
DEFA14A Additional proxy material Jun 27, 2024 —
DEF 14A Proxy statement Jun 27, 2024 Aug 13, 2024
8-K Current report
Officer or director change, Other events
Jun 24, 2024 Jun 24, 2024
8-K/A Amended current report Jun 24, 2024 Mar 27, 2024
8-K Current report
Other events
Jun 24, 2024 Jun 24, 2024
PRE 14A Preliminary proxy statement Jun 7, 2024 Jun 7, 2024
S-3 Shelf registration Jun 6, 2024 —
8-K/A Amended current report Jun 3, 2024 Mar 27, 2024
8-K Current report
Listing notice
May 23, 2024 May 20, 2024
10-Q Quarterly report May 13, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 13, 2024 May 13, 2024
D Filing Apr 9, 2024 —
10-K Annual report Mar 29, 2024 Dec 31, 2023
8-K Current report
Results of operations
Mar 29, 2024 Mar 29, 2024
DEFA14A Additional proxy material Mar 28, 2024 —
8-K Current report
Material agreement, Acquisition or sale of assets, Listing notice, Unregistered share sale, Officer or director change, Bylaw or fiscal year change, Other events
Mar 28, 2024 Mar 27, 2024
8-K Current report
Other events
Jan 31, 2024 Jan 30, 2024
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change
Dec 28, 2023 Dec 28, 2023
8-K Current report
Shareholder vote results
Dec 20, 2023 Dec 20, 2023
DEFA14A Additional proxy material Dec 7, 2023 —
8-K Current report
Other events
Dec 7, 2023 Dec 7, 2023
8-K Current report
Listing notice
Nov 16, 2023 Nov 14, 2023
10-Q Quarterly report Nov 9, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 9, 2023 Nov 9, 2023
8-K Current report
Acquisition or sale of assets, Other events
Oct 31, 2023 Oct 27, 2023
ARS Annual report to shareholders Oct 19, 2023 Dec 31, 2022
DEFA14A Additional proxy material Oct 19, 2023 —
DEF 14A Proxy statement Oct 19, 2023 Dec 5, 2023
8-K Current report
Bylaw or fiscal year change
Oct 17, 2023 Oct 16, 2023
PRE 14A Preliminary proxy statement Oct 5, 2023 Dec 5, 2023
8-K Current report Oct 3, 2023 Oct 3, 2023
8-K Current report
Material agreement, Other events
Sep 26, 2023 Sep 22, 2023
8-K Current report
Material agreement
Sep 13, 2023 Sep 13, 2023
8-K Current report
Listing notice, Other events
Sep 13, 2023 Sep 12, 2023
8-K Current report
Material agreement, Regulation FD disclosure
Sep 12, 2023 Sep 11, 2023
8-K Current report
Other events
Sep 11, 2023 Sep 11, 2023
8-K Current report
Material agreement, Other events
Aug 14, 2023 Aug 14, 2023
8-K Current report
Listing notice
Aug 8, 2023 Aug 8, 2023
8-K Current report
Material agreement
Aug 7, 2023 Aug 7, 2023
424B5 Prospectus supplement Aug 7, 2023 —
10-Q Quarterly report Aug 3, 2023 Jun 30, 2023
8-K Current report
Results of operations
Aug 3, 2023 Aug 3, 2023
8-K Current report
Material agreement, Other events
Jul 21, 2023 Jul 20, 2023
8-K Current report
Other events
Jun 26, 2023 Jun 26, 2023
8-K Current report
Material agreement, Unregistered share sale
Jun 2, 2023 May 31, 2023
S-8 Employee stock plan registration May 4, 2023 —
424B5 Prospectus supplement May 4, 2023 —
8-K Current report
Material agreement
May 4, 2023 May 4, 2023
10-Q Quarterly report May 4, 2023 Mar 31, 2023
8-K Current report
Results of operations
May 4, 2023 May 4, 2023
EFFECT Filing May 2, 2023 —
CORRESP Letter to the SEC Apr 28, 2023 —
EFFECT Filing Apr 27, 2023 —
POS AM Filing Apr 25, 2023 —
8-K Current report
Agreement ended
Apr 21, 2023 Apr 20, 2023
UPLOAD Letter from the SEC Apr 13, 2023 —
S-3 Shelf registration Apr 12, 2023 —
10-K Annual report Mar 29, 2023 Dec 31, 2022
8-K Current report
Results of operations
Mar 29, 2023 Mar 29, 2023
8-K Current report
Regulation FD disclosure
Mar 13, 2023 Mar 13, 2023
8-K Current report
Material agreement, Other events
Feb 3, 2023 Feb 2, 2023
424B5 Prospectus supplement Feb 3, 2023 —
424B5 Prospectus supplement Feb 2, 2023 —
8-K Current report
Regulation FD disclosure, Other events
Jan 17, 2023 Jan 17, 2023
8-K Current report
Acquisition or sale of assets
Nov 14, 2022 Nov 10, 2022
S-8 Employee stock plan registration Nov 7, 2022 —
10-Q Quarterly report Nov 7, 2022 Sep 30, 2022
8-K Current report
Results of operations
Nov 7, 2022 Nov 7, 2022
8-K Current report
Other events
Aug 16, 2022 Aug 16, 2022
8-K Current report
Material agreement, Officer or director change, Other events
Aug 11, 2022 Aug 8, 2022
10-Q Quarterly report Aug 4, 2022 Jun 30, 2022
8-K Current report
Results of operations
Aug 4, 2022 Aug 4, 2022
8-K Current report
Material agreement, Other events
Aug 1, 2022 Jul 29, 2022
8-K Current report
Other events
Jul 22, 2022 Jul 22, 2022
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change
Jul 7, 2022 Jul 7, 2022
8-K Current report
Shareholder vote results
Jun 14, 2022 Jun 14, 2022
8-K Current report
Other events
May 24, 2022 May 18, 2022
10-Q Quarterly report May 5, 2022 Mar 31, 2022
8-K Current report
Results of operations
May 5, 2022 May 5, 2022
DEFA14A Additional proxy material Apr 25, 2022 —
DEF 14A Proxy statement Apr 25, 2022 Jun 14, 2022
PRE 14A Preliminary proxy statement Apr 4, 2022 Jun 14, 2022
8-K Current report
Listing notice
Mar 18, 2022 Mar 17, 2022
8-K Current report
Other events
Mar 16, 2022 Mar 16, 2022
10-K Annual report Mar 2, 2022 Dec 31, 2021
8-K Current report
Results of operations
Mar 2, 2022 Mar 2, 2022
8-K Current report
Officer or director change
Feb 18, 2022 Feb 14, 2022
8-K Current report
Officer or director change
Feb 8, 2022 Feb 2, 2022
8-K Current report
Other events
Jan 6, 2022 Jan 6, 2022
8-K Current report
Other events
Dec 15, 2021 Dec 14, 2021
8-K Current report
Officer or director change, Other events
Dec 6, 2021 Dec 1, 2021
10-Q Quarterly report Nov 9, 2021 Sep 30, 2021
8-K Current report
Results of operations
Nov 9, 2021 Nov 9, 2021
8-K Current report
Officer or director change
Oct 18, 2021 Oct 15, 2021
8-K Current report
Material agreement, Other events
Sep 15, 2021 Sep 14, 2021
424B5 Prospectus supplement Sep 15, 2021 —
424B5 Prospectus supplement Sep 14, 2021 —
8-K Current report
Regulation FD disclosure
Sep 9, 2021 Sep 9, 2021
8-K Current report
Bylaw or fiscal year change, Other events
Aug 26, 2021 Aug 26, 2021
10-Q Quarterly report Aug 2, 2021 Jun 30, 2021
8-K Current report
Results of operations
Aug 2, 2021 Aug 2, 2021
8-K Current report
Regulation FD disclosure, Other events
Jul 26, 2021 Jul 26, 2021
8-K Current report
Material agreement, Other events
Jul 2, 2021 Jul 2, 2021
424B5 Prospectus supplement Jul 2, 2021 —
8-K Current report
Material agreement, Other events
Jun 23, 2021 Jun 22, 2021
8-K Current report
Officer or director change
Jun 21, 2021 Jun 15, 2021
8-K Current report
Shareholder vote results
Jun 16, 2021 Jun 15, 2021
8-K Current report
Material agreement, New debt
Jun 8, 2021 Jun 4, 2021
S-8 Employee stock plan registration May 13, 2021 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
AVTX (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Wayne, PA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1534120
Former names
Cerecor Inc. (until Aug 18, 2021)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.